I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Development and validation of a decision model for the eval..:
Mfumbilwa, Zakile A
;
Wilschut, Janneke A
;
Simons, Martijn J H G
...
2045-2322. , 2023
Link:
https://dspace.library.uu.nl/handle/1874/427599
RT Journal T1
Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands
UL https://suche.suub.uni-bremen.de/peid=base-ftunivutrecht:oai:dspace.library.uu.nl:1874_427599&Exemplar=1&LAN=DE A1 Mfumbilwa, Zakile A A1 Wilschut, Janneke A A1 Simons, Martijn J H G A1 Ramaekers, Bram A1 Joore, Manuela A1 Retèl, Valesca A1 der Welle, Christine M Cramer-van A1 Schramel, Franz M N H A1 van de Garde, Ewoudt M W A1 Coupé, Veerle M H YR 2023 K1 Humans K1 Antineoplastic Agents/adverse effects K1 Netherlands K1 Cost-Benefit Analysis K1 Lung Neoplasms/drug therapy K1 Carcinoma K1 Non-Small-Cell Lung/drug therapy K1 Antineoplastic Combined Chemotherapy Protocols/therapeutic use K1 Competing risks K1 Multicenter K1 Tyrosine kinase inhibitors K1 Survival outcomes K1 Cost-effectiveness analysis K1 Chemotherapy K1 Pembrolizumab K1 Simulation K1 Immunotherapy K1 1st-line therapy JF 2045-2322 LK http://dx.doi.org/https://dspace.library.uu.nl/handle/1874/427599 DO https://dspace.library.uu.nl/handle/1874/427599 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)